within Pharmacolibrary.Drugs.ATC.L;

model L01XX77
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.34,
    Cl             = 26.8 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 600 / 1000000,
    adminCount     = 1,
    Vd             = 0.167,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006666666666666667,
    Tlag           = 12.6
  );

  annotation(Documentation(
    info ="<html><body><p>Adagrasib is an orally active, irreversible KRAS G12C inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with KRAS G12C mutation. It is approved for medical use for this indication.</p><h4>Pharmacokinetics</h4><p>Population pharmacokinetic parameters in adult patients with advanced solid tumors (predominantly NSCLC), both sexes, median age ~65 years.</p><h4>References</h4><ol><li><p>Ou, SI, et al., &amp; Papadopoulos, KP (2022). First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced . <i>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</i> 40(23) 2530–2538. DOI:<a href=&quot;https://doi.org/10.1200/JCO.21.02752&quot;>10.1200/JCO.21.02752</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35167329/&quot;>https://pubmed.ncbi.nlm.nih.gov/35167329</a></p></li><li><p>Loos, NHC, et al., &amp; Schinkel, AH (2023). Pharmacokinetics of the KRAS. <i>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</i> 166 115304–None. DOI:<a href=&quot;https://doi.org/10.1016/j.biopha.2023.115304&quot;>10.1016/j.biopha.2023.115304</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37586117/&quot;>https://pubmed.ncbi.nlm.nih.gov/37586117</a></p></li><li><p>Sabari, JK, et al., &amp; Wakimoto, H (2022). Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non-Small Cell Lung Cancer. <i>Clinical cancer research : an official journal of the American Association for Cancer Research</i> 28(15) 3318–3328. DOI:<a href=&quot;https://doi.org/10.1158/1078-0432.CCR-22-0383&quot;>10.1158/1078-0432.CCR-22-0383</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35404402/&quot;>https://pubmed.ncbi.nlm.nih.gov/35404402</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01XX77;
